The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorCliment Duran, M. A.
dc.contributor.authorVidal, N.
dc.contributor.authorPerez, S.
dc.contributor.authorMendez-Vidal, M. J.
dc.contributor.authorAnguera, G.
dc.contributor.authorMartinez Salas, I.
dc.contributor.authorGallardo, E.
dc.contributor.authorCuellar, M. A.
dc.contributor.authorSoto, J. J.
dc.contributor.authorMartin, A.
dc.contributor.authorDomenech, M.
dc.contributor.authorRodriguez-Vida, A.
dc.contributor.authorAlmagro Casado, E.
dc.contributor.authorDiaz-Mejia, N.
dc.contributor.authorMartinez Kareaga, M.
dc.contributor.authorFernandez Calvo, O.
dc.contributor.authorVilla Guzman, J. C.
dc.contributor.authorVazquez, S.
dc.contributor.authorGonzalez del Alba, A.
dc.contributor.authorPuente, J.
dc.contributor.authoraffiliation[Climent Duran, M. A.] Inst Valenciano Oncol, Med Oncol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Vidal, N.] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos Id, Med Oncol Dept, CIBERONC, Madrid, Spain
dc.contributor.authoraffiliation[Puente, J.] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos Id, Med Oncol Dept, CIBERONC, Madrid, Spain
dc.contributor.authoraffiliation[Perez, S.] Hosp Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Mendez-Vidal, M. J.] Univ Reina Sofia, Maimonides Inst Biomed Res, Cordoba IMIBIC Hosp, Med Oncol Dept, Cordoba, Spain
dc.contributor.authoraffiliation[Anguera, G.] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Martinez Salas, I.] Fdn Jimenez Diaz, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Gallardo, E.] Parc Tauli Hosp Univ, Med Oncol Dept, Inst Invest & Innovacio Parc Tauli I3PT, Sabadell, Spain
dc.contributor.authoraffiliation[Cuellar, M. A.] ICO LHospitalet Llobregat, Med Oncol Dept, Inst Catala Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Soto, J. J.] Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Martin, A.] Hosp Univ Infanta Leonor, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Domenech, M.] Med Oncol Dept, Fdn Althaia, Manresa, Spain
dc.contributor.authoraffiliation[Rodriguez-Vida, A.] Hosp Mar, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Almagro Casado, E.] Hosp Univ Quiron Salud Madrid, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Diaz-Mejia, N.] Hosp Univ Vall Hebron, Vall dHebron Inst Oncol VHIO, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Martinez Kareaga, M.] Hosp Txagorritxu, Med Oncol Dept, Vitoria, Spain
dc.contributor.authoraffiliation[Fernandez Calvo, O.] Complejo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
dc.contributor.authoraffiliation[Villa Guzman, J. C.] Hosp Gen Univ Ciudad Real, Med Oncol Dept, Ciudad Real, Spain
dc.contributor.authoraffiliation[Vazquez, S.] Hosp Univ Lucus Augusti, Med Oncol Dept, Lugo, Spain
dc.contributor.authoraffiliation[Gonzalez del Alba, A.] Hosp Univ Puerta Hierro Majadahonda, Med Oncol Dept, Madrid, Spain
dc.contributor.funderAstellas Pharma
dc.contributor.funderAstraZeneca
dc.contributor.funderBristol Myers Squibb
dc.contributor.funderIpsen Pharma
dc.contributor.funderNovartis
dc.contributor.funderPfizer
dc.date.accessioned2025-01-07T17:08:25Z
dc.date.available2025-01-07T17:08:25Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1565
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1565
dc.identifier.urihttps://hdl.handle.net/10668/28195
dc.identifier.wosID700527703118
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.numberS1136-S1137
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleThe impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía